Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA:600420)
8.49
+0.01 (0.12%)
Sep 4, 2026, 3:00 PM CST
SHA:600420 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 8,425 | 9,363 | 10,938 | 12,070 | 12,959 | 13,945 |
Revenue Growth | -14.51% | -14.39% | -9.38% | -6.86% | -7.07% | 11.06% |
Gross Profit Gross Profit Growth | 2,377 | 2,925 | 4,116 | 4,532 | 4,868 | 6,036 |
Operating Income Operating Income Growth | 727.02 | 1,114 | 1,553 | 983.4 | 841.24 | 1,078 |
Net Income Net Income Growth | 545.12 | 941.6 | 1,084 | 691.88 | 627.79 | 568.28 |
Earnings Per Share EPS Growth | 0.41 | 0.70 | 0.81 | 0.54 | 0.54 | 0.48 |
EPS Growth | -47.44% | -13.11% | 48.72% | 0.07% | 12.52% | -12.29% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
North-East China North-East China Growth | 397.53 | 397.37 | 509.69 |
North-West China North-West China Growth | 401.12 | 421.66 | 573.17 |
North China North China Growth | 1,212 | 1,500 | 1,427 |
East China East China Growth | 2,339 | 2,809 | 3,202 |
Central China Central China Growth | 918.69 | 943.59 | 1,181 |
Southern China Southern China Growth | 1,269 | 1,108 | 1,237 |
South-West China South-West China Growth | 876.14 | 1,080 | 1,260 |
Overseas Overseas Growth | 1,909 | 2,584 | 2,467 |
Total Total Growth | 9,323 | 10,842 | 11,857 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 3,513 | 7,061 | 7,643 | 5,973 | 6,148 | 4,284 |
Total Debt Total Debt Growth | 37.29 | 42.6 | 1,138 | 1,145 | 3,403 | 4,184 |
Net Cash (Debt) Net Cash Growth | 3,475 | 7,018 | 6,505 | 4,828 | 2,745 | 99.84 |
Net Cash Growth | -45.52% | 7.89% | 34.74% | 75.89% | 2649.36% | - |
Net Cash Per Share Net Cash Per Share Growth | 2.59 | 5.23 | 4.85 | 3.79 | 2.37 | 0.08 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,078 | 1,698 | 2,256 | 1,720 | 2,856 | 1,680 |
Capital Expenditures CapEx Growth | -233.2 | -263.83 | -219.77 | -357.19 | -307.44 | -521.44 |
Free Cash Flow Free Cash Flow Growth | 845.19 | 1,434 | 2,036 | 1,363 | 2,548 | 1,158 |
Free Cash Flow Growth | -1.46% | -29.56% | 49.37% | -46.50% | 120.01% | -2.03% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 28.21% | 31.25% | 37.63% | 37.55% | 37.57% | 43.28% |
Operating Margin | 8.63% | 11.89% | 14.19% | 8.15% | 6.49% | 7.73% |
Pretax Margin | 10.04% | 14.18% | 15.30% | 9.09% | 7.59% | 6.58% |
Profit Margin | 6.47% | 10.06% | 9.91% | 5.73% | 4.84% | 4.08% |
FCF Margin | 10.03% | 15.32% | 18.62% | 11.29% | 19.66% | 8.31% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.300 | 0.300 | 0.300 | 0.100 | 0.100 | 0.100 |
Dividend Per Share Growth | 50.00% | 0% | 200.00% | 0% | 0% | 0% |
Dividend Yield | 3.53% | 3.04% | 2.64% | 1.09% | 1.19% | 1.05% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 20.89 | 14.39 | 14.78 | 18.98 | 14.89 | 18.74 |
Forward PE | - | 11.16 | 11.94 | 10.42 | 10.42 | 10.42 |
P/FCF Ratio | 13.47 | 9.44 | 7.86 | 9.63 | 3.67 | 9.20 |
PS Ratio | 1.35 | 1.45 | 1.46 | 1.09 | 0.72 | 0.76 |